1989
DOI: 10.1007/bf02367467
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacokinetic modeling of ethyl loflazepate (VictanR) and its main active metabolites

Abstract: A simultaneous consideration of plasma and urine data of unchanged drug and active metabolites, taking into account the metabolic process of the precursor, is described. The maximum likelihood principle was used to estimate parameters. This methodology is highly efficient in determining the contribution of the two main and active metabolites in the pharmacological response of ethyl loflazepate. It also may serve in the search for optimum dosage regimens in clinical practice.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

1996
1996
2024
2024

Publication Types

Select...
2
2
1

Relationship

0
5

Authors

Journals

citations
Cited by 161 publications
(7 citation statements)
references
References 8 publications
0
7
0
Order By: Relevance
“…Indeed, n occupies a linear position in the model and it merits a special consideration in the estimation procedure [18,24].…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Indeed, n occupies a linear position in the model and it merits a special consideration in the estimation procedure [18,24].…”
Section: Discussionmentioning
confidence: 99%
“…Further, reconsider the estimation procedure by eliminating the linear parameter n in the non-linear regression [18,24].…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations